Population
Patients with hypertension
Design
Review
Authors
Loading...
May support weighing metabolic effects in antihypertensive selection; leaves open impact on atherosclerosis progression beyond BP control.
The selection of antihypertensive therapy should consider effects beyond blood pressure reduction, such as metabolic impacts, left ventricular hypertrophy, and renal protection.
Norman K. Hollenberg (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: